About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pittsburgh | 10,697 Studies Near You

Clinical TrialsPittsburgh

Clinical Trials in Pittsburgh

Discover 10,697 clinical trials near Pittsburgh, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2241-2260 of 10,697 trials

CompletedCombination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00022126·Phoenix, Arizona and 50 others

Find Trials by Condition in Pittsburgh

Breast Cancerin Pittsburgh Lung Cancerin Pittsburgh Prostate Cancerin Pittsburgh Colorectal Cancerin Pittsburgh Melanomain Pittsburgh Leukemiain Pittsburgh Lymphomain Pittsburgh Pancreatic Cancerin Pittsburgh Ovarian Cancerin Pittsburgh Brain Cancerin Pittsburgh

Data from ClinicalTrials.govTerms

CompletedEight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)This study will evaluate the effectiveness and safety of the investigational drug talnetant in treating subjects with irritable bowel syndrome (IBS).NCT00101985·Chandler, Arizona and 134 others

CompletedPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well palbociclib works in treating patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with…NCT03526250·Birmingham, Alabama and 116 others

CompletedA Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainThis study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the…NCT00196313·Denver, Colorado and 12 others

CompletedRivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric SubjectsThe first study with rivaroxaban in pediatric subjects is a Phase I study, where the pharmacokinetic/pharmacodynamic (PK/PD) profile of rivaroxaban will be investigated to confirm…NCT01145859·Little Rock, Arkansas and 35 others

CompletedHIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.Project Aware is a randomized controlled clinical trial in which individuals seeking medical or health services at sexually transmitted disease (STD) clinics are recruited to…NCT01154296·Los Angeles, California and 8 others

Active not recruitingPsoriasis Longitudinal Assessment and RegistryThe purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis.NCT00508547·Birmingham, Alabama and 319 others

CompletedStudy to Evaluate Multiple Doses in Patients With Nasal PolyposisThis is a phase 2 study to evaluate multiple doses of AK001 across 2 active doses. Pharmacodynamic activity will also be evaluated.NCT02734849·Chicago, Illinois and 14 others

CompletedERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell CarcinomaThere are currently no useful tests to identify patients who will respond to cetuximab therapy, notably because EGFR levels do not correlate with the clinical responses observed.NCT01218048·Pittsburgh, Pennsylvania

CompletedScreening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe DiseasePompe disease (also known as glycogen storage disease type II) is caused by a deficiency of a critical enzyme in the body called acid alpha-glucosidase (GAA).NCT00113035·Beverly Hills, California and 4 others

CompletedImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaRATIONALE: Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01273090·Birmingham, Alabama and 22 others

CompletedTime-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's DiseaseDementia caused by Alzheimer's disease affects approximately 5.6 million adults over age 65, with costs expected to rise from $307 billion to $1.5 trillion over the next 30 years.NCT05138848·Pittsburgh, Pennsylvania

TerminatedA Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid MalignanciesThe purpose of this study is to assess the safety and tolerability of multiple escalating doses of BMS-663513 when given in combination with paclitaxel and carboplatin.NCT00351325·Philadelphia, Pennsylvania and 4 others

CompletedBuoy Electrolyte Study on Hydration Status of Active Men and WomenBuoy is an all-natural, organic, FDA compliant dietary electrolyte supplement that can be dissolved in 8-12oz water (or other liquid) and provide electrolytes in servings of 1/3…NCT05768789·Pittsburgh, Pennsylvania and 1 other

CompletedA Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal CancerThis is an open label, single-arm, Phase 2 trial to evaluate the anti-tumor activity, safety, and tolerability of Pembrolizumab in combination with azacitidine in subjects with…NCT02260440·Pittsburgh, Pennsylvania

UnknownSP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV PatientsThis is a 28-day, multi-center, placebo-controlled study designed to look at the dose response, efficacy, and safety of SP01A, given as a pill to be swallowed, in the treatment of…NCT00299897·Beverly Hills, California and 4 others

CompletedA Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasThe purpose of this trial is to understand if adding saxagliptin to a sulfonylurea is safe and works better than increasing the amount of sulfonylurea a patient takesNCT00313313·Jonesboro, Arkansas and 114 others

CompletedSunitinib in Treating Young Patients With Refractory Solid TumorsThis phase I trial is studying the side effects and best dose of sunitinib in treating young patients with refractory solid tumors.NCT00387920·Birmingham, Alabama and 16 others

CompletedTargeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac ArrestILCOR guidelines recommend Target Temperature Management (TTM) to between 32°C and 36°C after out-of-hospital cardiac arrest, based on low quality evidence.NCT02908308·Rochester, New York and 59 others

RecruitingJAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through RandomizationProspective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population.NCT05064540·Huntsville, Alabama and 28 others

PreviousPage 113 of 535Next

Diabetes

in Pittsburgh

Heart Diseasein Pittsburgh